DexCom, Inc. (DXCM) 의 후행 P/E는 30.1, 선행 P/E 25.3. 후행 이익수익률은 3.33%, 선행 이익수익률 3.95%. PEG 0.64 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $18.59.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 82/100 7/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | -76.1 | -6.85 | 17.59 | 8.71 | - |
| 2017 | -98.7 | 3.95 | 11.81 | 6.89 | - |
| 2018 | -83.1 | -0.59 | 15.93 | 10.24 | - |
| 2019 | 197.1 | -1.11 | 22.58 | 13.50 | - |
| 2020 | 70.7 | 0.19 | 19.11 | 18.11 | - |
| 2021 | 239.5 | -4.18 | 25.43 | 21.21 | - |
| 2022 | 129.2 | 2.26 | 20.68 | 15.15 | - |
| 2023 | 88.5 | 1.39 | 23.16 | 13.22 | - |
| 2024 | 54.6 | 39.32 | 14.97 | 7.80 | - |
| 2025 | 31.0 | 0.66 | 9.43 | 5.56 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $-0.20 | $573.3M | $-65.6M | -11.4% |
| 2017 | $-0.15 | $718.5M | $-50.2M | -7% |
| 2018 | $-0.36 | $1.03B | $-127.1M | -12.3% |
| 2019 | $0.27 | $1.48B | $101.1M | 6.8% |
| 2020 | $1.27 | $1.93B | $493.6M | 25.6% |
| 2021 | $0.36 | $2.45B | $154.7M | 6.3% |
| 2022 | $0.80 | $2.91B | $341.2M | 11.7% |
| 2023 | $1.30 | $3.62B | $541.5M | 14.9% |
| 2024 | $1.42 | $4.03B | $576.2M | 14.3% |
| 2025 | $2.09 | $4.66B | $836.3M | 17.9% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $2.49 | $2.38 – $2.56 | $5.23B | $5.19B – $5.35B | 15 |
| 2027 | $2.99 | $2.75 – $3.31 | $5.86B | $5.78B – $6.09B | 14 |
| 2028 | $3.59 | $3.20 – $3.99 | $6.57B | $6.55B – $6.58B | 6 |
| 2029 | $4.26 | $4.18 – $4.43 | $7.48B | $7.38B – $7.72B | 4 |
| 2030 | $5.02 | $4.93 – $5.22 | $8.6B | $8.48B – $8.87B | 2 |
